Tumor-derived VEGFA, IL-10 and prostaglandin E2 cooperatively induce upregulation of the death mediator Fas ligand (FasL) in ECs which gain the ability to kill effector CD8+ T cells but not Treg cells (due to expression of FoxP3) (100) (Figure 1D). Here, CD8A is linked to neoplasm.